Nanjing Vazyme Biotech Co., Ltd (SHA:688105)
China flag China · Delayed Price · Currency is CNY
20.24
-0.75 (-3.57%)
May 12, 2026, 3:00 PM CST

Nanjing Vazyme Biotech Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
8,3487,9638,81112,80821,25742,401
Market Cap Growth
-8.25%-9.63%-31.21%-39.74%-49.87%-
Enterprise Value
6,4096,1006,99510,67018,87741,383
Last Close Price
20.9920.0222.0231.6150.47100.29
PE Ratio
----35.7762.51
Forward PE
51.2074.6243.6948.0323.2157.10
PS Ratio
5.915.786.409.965.9622.69
PB Ratio
2.202.102.233.184.6110.27
P/TBV Ratio
2.332.232.373.374.8010.32
P/FCF Ratio
-42.86---119.49
P/OCF Ratio
-34.15-83.7228.9168.74
EV/Sales Ratio
4.534.435.088.305.2922.15
EV/EBITDA Ratio
-85.36--20.6654.37
EV/EBIT Ratio
----22.2056.70
EV/FCF Ratio
-32.84---116.63
Debt / Equity Ratio
0.270.220.190.320.100.02
Debt / EBITDA Ratio
10.9110.9529.87-0.470.12
Debt / FCF Ratio
6.004.54---0.26
Net Debt / Equity Ratio
-0.51-0.53-0.48-0.54-0.61-0.81
Net Debt / EBITDA Ratio
-22.25-28.15109.4712.62-3.07-4.42
Net Debt / FCF Ratio
-11.51-10.8322.5227.4512.32-9.48
Asset Turnover
0.270.270.260.220.670.60
Inventory Turnover
1.171.191.241.454.592.08
Quick Ratio
3.043.193.502.533.569.76
Current Ratio
3.393.563.952.783.9610.46
Return on Equity (ROE)
-0.58%-0.58%-0.49%-1.69%13.58%24.85%
Return on Assets (ROA)
-0.28%-0.44%-1.31%-2.89%10.02%14.67%
Return on Invested Capital (ROIC)
-1.28%-1.88%-5.83%-14.91%64.41%119.81%
Return on Capital Employed (ROCE)
-0.60%-0.90%-2.70%-6.40%17.50%17.30%
Earnings Yield
-0.18%-0.21%-0.21%-0.55%2.80%1.60%
FCF Yield
-2.33%-0.96%-0.62%-1.07%0.84%
Dividend Yield
2.38%-0.82%0.32%2.48%0.30%
Payout Ratio
----22.25%0.66%
Buyback Yield / Dilution
-29.79%-14.77%8.20%1.16%-9.95%-1.97%
Total Shareholder Return
-27.34%-14.77%9.02%1.47%-7.48%-1.67%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.